MIP3alpha-scFv DNA vaccine (MD Anderson Cancer Center)
N/A
Report date: 2026/03/27 20:01:50
Base Information
Drug NameMIP3alpha-scFv DNA vaccine (MD Anderson Cancer Center)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeckman Research Institute City Of HopeThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesBeckman Research Institute City Of Hope
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A